SUBSCRIBE
SUBSCRIBE

Gene editing

Pictured: An FDA blue van drives towards cardiac-s
Policy
Regulatory Pathway Widening for Cardiac Gene Therapy Hopefuls
Separate challenges exist for companies developing gene therapies for rare and common cardiovascular conditions, experts told BioSpace.
March 6, 2024
 · 
5 min read
 · 
Kate Goodwin
Pictured: Baisong Mei/Nicole Bean for BioSpace
Business
Baisong Mei’s Immigrant Journey Through American Biopharma
From entering college in China at just 15 to co-inventing a drug for Bayer, Mei’s career journey has been far from average. Now CMO at Editas, he’s not done yet.
February 27, 2024
 · 
4 min read
 · 
Mollie Barnes
Drug Development
First ever CRISPR gene therapy approval: What happens next?
CRISPR gene-editing has had its first ever approval in the UK. Will the FDA follow suit? What can patients expect the price tag to be?
November 21, 2023
 · 
1 min read
 · 
Greg Slabodkin
Load More
PRESS RELEASES
Press Releases
Precision BioSciences to Report Second Quarter 2025 Results on August 7, 2025
August 5, 2025
 · 
1 min read
Press Releases
Arbor Biotechnologies Announces First Patient Dosed at Mayo Clinic in the redePHine Phase 1/2 Study of ABO-101, an Investigational Gene Editing Treatment for Primary Hyperoxaluria Type 1
July 31, 2025
 · 
5 min read
Press Releases
Precision BioSciences Receives FDA Orphan Drug Designation for PBGENE-DMD for the Treatment of Duchenne Muscular Dystrophy
July 23, 2025
 · 
9 min read
Press Releases
Synthego Announces Successful Close of Acquisition by Perceptive Advisors
July 22, 2025
 · 
2 min read
Press Releases
Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy
July 17, 2025
 · 
2 min read
Press Releases
Integrated DNA Technologies Announces Translational CRISPR Portfolio Expansion with Product Innovation Updates
July 17, 2025
 · 
4 min read
Press Releases
Chan Zuckerberg Initiative, Innovative Genomics Institute Announce New Center for Pediatric CRISPR Cures
July 8, 2025
 · 
4 min read
Press Releases
CRISPR Therapeutics Named to TIME’s Most Influential Companies List of 2025
July 1, 2025
 · 
2 min read
Press Releases
DUBRETON CALLS FOR MANDATORY LABELING OF GENE-EDITED PORK IN NORTH AMERICA
July 1, 2025
 · 
2 min read
Press Releases
Synthego Gains Approval to Proceed with Sale to Perceptive Advisors; Transaction Set to Close in July
June 27, 2025
 · 
2 min read
Press Releases
Synthego Prevails In Patent Appeal Confirming Agilent CRISPR Patents Are Invalid
June 12, 2025
 · 
1 min read
Press Releases
SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer
June 12, 2025
 · 
3 min read
Press Releases
Taconic Biosciences Enters Into an Exclusive License Agreement With Helmholtz Munich to Expand Its CRISPR/Cas9 Gene Editing Services
June 9, 2025
 · 
2 min read
Press Releases
SOLVE FSHD and Modalis Announce Strategic Collaboration to Develop an Innovative CRISPR-Based Epigenome Editing Treatment for Facioscapulohumeral Muscular Dystrophy
June 9, 2025
 · 
3 min read
Press Releases
GenEditBio Announces First Patient Dosed in Investigator-Initiated Trial of GEB‑101, World’s First In Vivo CRISPR-Cas Ribonucleoprotein-Based Genome Editing Investigational Therapy for TGFBI Corneal Dystrophy
June 6, 2025
 · 
5 min read
Press Releases
Scribe Therapeutics Reports Positive Preclinical Data on its Novel CRISPR Technologies at the 2025 EAS Congress and ASGCT Annual Meeting
May 22, 2025
 · 
5 min read
Press Releases
CRISPR Therapeutics and Sirius Therapeutics Announce Multi-Target Collaboration to Develop Novel siRNA Therapies
May 20, 2025
 · 
10 min read
Press Releases
Acuitas Therapeutics Showcases Collaboration with Children’s Hospital of Philadelphia for Personalized CRISPR Therapy and New LNP Research at ASGCT 2025
May 16, 2025
 · 
6 min read
Press Releases
World’s First Patient Treated with Personalized CRISPR Gene Editing Therapy at Children’s Hospital of Philadelphia
May 15, 2025
 · 
8 min read
Press Releases
First Patient Treated with Personalized CRISPR Therapy, Developed in Just Six Months
May 15, 2025
 · 
7 min read
Load More